{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:25:55Z","timestamp":1787772355679,"version":"build-2784847793"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>As visceral protein expression may influence outcomes in patients with cardiovascular disease, we investigated whether pre-procedural albumin concentration is associated with length of stay (LOS) and 90-day mortality after transcatheter aortic valve repair (TAVR).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>We retrospectively analyzed data from TAVR patients at our institution between January 2013 and December 2017. For all patients, baseline albumin concentration was assessed between one and four weeks before the procedure. To investigate the association between albumin concentration and outcomes, we performed regression analyses, controlling for Society of Thoracic Surgeons, New York Heart Association classification, and Kansas City Cardiomyopathy Questionnaire 12 scores.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Three hundred eighty patients were included in the analyses. Cox-proportional hazards regression showed that patients with albumin concentrations &lt;3.5 g\/dL were 80% more likely to have prolonged ICU LOS (HR 1.79; 95%CI 1.04\u20132.57,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.03) and 70% more likely to have prolonged hospital LOS (HR 1.68; 95%CI 1.01-2.46,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.04) compared to patients with albumin concentrations &gt;3.5 g\/dL. Logistic regression showed that patients with albumin concentrations &lt;3.5 g\/dL were four times more likely to not survive to 90 days (OR 3.94; 1.13\u201312.63,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.03) after their TAVR compared to patients with albumin concentrations &gt;3.5 g\/dL.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Our data suggest that patients with pre-procedural albumin concentrations &lt;3.5 g\/dL are at an increased risk of adverse outcomes after TAVR compared to patients with albumin concentrations \u22653.5 g\/dL. Prospective studies are needed to determine whether risk stratification based on pre-procedural albumin can improve outcomes and whether targeted interventions can improve pre-procedural albumin concentrations in potential TAVR candidates.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/aca.aca_114_21","type":"journal-article","created":{"date-parts":[[2024,5,28]],"date-time":"2024-05-28T05:52:05Z","timestamp":1716875525000},"page":"72-77","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":9,"title":["Pre-Procedural Serum Albumin Concentration is Associated with Length of Stay, Discharge Destination, and 90-Day Mortality in Patients After Transcatheter Aortic Valve Replacement"],"prefix":"10.4103","volume":"26","author":[{"given":"Najla Y.","family":"Beydoun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lyubov","family":"Tsytsikova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haesun","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Furzan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Weintraub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fredrick","family":"Cobey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadeq A.","family":"Quraishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-12-20240901","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.jacc.2013.05.015","article-title":"Aortic stenosis in the elderly: Disease prevalence and number of candidates for transcatheter aortic valve replacement: A meta-analysis and modeling study","volume":"62","author":"Osnabrugge","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"R2-12-20240901","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1161\/CIRCOUTCOMES.112.966002","article-title":"Five-year clinical and economic outcomes among patients with medically managed severe aortic stenosis: Results from a Medicare claims analysis","volume":"5","author":"Clark","year":"2012","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"R3-12-20240901","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1136\/hrt.82.2.143","article-title":"To operate or not on elderly patients with aortic stenosis: The decision and its consequences","volume":"82","author":"Bouma","year":"1999","journal-title":"Heart"},{"key":"R4-12-20240901","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.1093\/eurheartj\/ehi471","article-title":"Decision-making in elderly patients with severe aortic stenosis: Why are so many denied surgery?","volume":"26","author":"Iung","year":"2005","journal-title":"Eur Heart J"},{"key":"R5-12-20240901","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1161\/CIRCOUTCOMES.109.848259","article-title":"Evaluation of patients with severe symptomatic aortic stenosis who do not undergo aortic valve replacement: The potential role of subjectively overestimated operative risk","volume":"2","author":"Bach","year":"2009","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"R6-12-20240901","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1056\/NEJMoa1008232","article-title":"Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery","volume":"363","author":"Leon","year":"2010","journal-title":"N Engl J Med"},{"key":"R7-12-20240901","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1001\/jamacardio.2019.4657","article-title":"Utility of 90-day mortality vs 30-day mortality as a quality metric for transcatheter and surgical aortic valve replacement outcomes","volume":"5","author":"Hirji","year":"2020","journal-title":"JAMA Cardiol"},{"key":"R9-12-20240901","doi-asserted-by":"crossref","first-page":"A579","DOI":"10.1016\/j.jval.2017.08.1027","article-title":"Comparison of US hospital costs between transcatheter aortic valve replacement (TAVR) and surgical aortic valve replacement (SAVR)","volume":"20","author":"Meduri","year":"2017","journal-title":"Value Health"},{"key":"R10-12-20240901","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.jcin.2019.02.049","article-title":"Habitual physical activity in older adults undergoing TAVR: Insights from the FRAILTY-AVR studys","volume":"12","author":"Sathananthan","year":"2019","journal-title":"JACC Cardiovasc Interv"},{"key":"R11-12-20240901","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.jcin.2012.06.011","article-title":"The impact of frailty status on survival after transcatheter aortic valve replacement in older adults with severe aortic stenosis: A single-center experience","volume":"5","author":"Green","year":"2012","journal-title":"JACC Cardiovasc Interv"},{"key":"R12-12-20240901","doi-asserted-by":"crossref","first-page":"6763","DOI":"10.21037\/jtd.2018.11.30","article-title":"Effect of preoperative low serum albumin on postoperative complications and early mortality in patients undergoing transcatheter aortic valve replacement","volume":"10","author":"Gassa","year":"2018","journal-title":"J Thorac Dis"},{"key":"R13-12-20240901","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/j.athoracsur.2018.06.024","article-title":"Albumin Is predictive of 1-year mortality after transcatheter aortic valve replacement","volume":"106","author":"Hebeler","year":"2018","journal-title":"Ann Thorac Surg"},{"key":"R14-12-20240901","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1080\/01621459.1979.10481038","article-title":"Robust locally weighted regression and smoothing scatterplots","volume":"74","author":"Cleveland","year":"1979","journal-title":"J Am Stat Assoc"},{"key":"R15-12-20240901","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1080\/01621459.1988.10478639","article-title":"Locally weighted regression: An approach to regression analysis by local fitting","volume":"83","author":"Cleveland","year":"1988","journal-title":"J Am Stat Assoc"},{"key":"R18-12-20240901","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1002\/ejhf.2011","article-title":"Cachexia, muscle wasting, and frailty in cardiovascular disease","volume":"22","author":"Bielecka-Dabrowa","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"R19-12-20240901","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1177\/0148607191015002207","article-title":"Role of albumin in human physiology and pathophysiology","volume":"15","author":"Doweiko","year":"1991","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"R20-12-20240901","doi-asserted-by":"crossref","first-page":"229","DOI":"10.2147\/IJGM.S102819","article-title":"Human serum albumin homeostasis: A new look at the roles of synthesis, catabolism, renal and gastrointestinal excretion, and the clinical value of serum albumin measurements","volume":"9","author":"Levitt","year":"2016","journal-title":"Int J Gen Med"},{"key":"R21-12-20240901","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0167-5273(02)00233-4","article-title":"The syndrome of cardiac cachexia","volume":"85","author":"Anker","year":"2002","journal-title":"Int J Cardiol"},{"key":"R22-12-20240901","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1053\/euhj.1998.1446","article-title":"Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure","volume":"20","author":"Anker","year":"1999","journal-title":"Eur Heart J"},{"key":"R23-12-20240901","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1056\/NEJM196408272710908","article-title":"The pathogenesis of cardiac cachexia","volume":"271","author":"Pittman","year":"1964","journal-title":"N Engl J Med"},{"key":"R24-12-20240901","doi-asserted-by":"crossref","first-page":"860","DOI":"10.7326\/0003-4819-121-11-199412010-00006","article-title":"Increased resting metabolic rate in patients with congestive heart failure","volume":"121","author":"Poehlman","year":"1994","journal-title":"Ann Intern Med"},{"key":"R25-12-20240901","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1161\/01.CIR.96.2.526","article-title":"Hormonal changes and catabolic\/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia","volume":"96","author":"Anker","year":"1997","journal-title":"Circulation"},{"key":"R26-12-20240901","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/01.mco.0000222103.29009.70","article-title":"Angiotensin II as candidate of cardiac cachexia","volume":"9","author":"Delafontaine","year":"2006","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"R27-12-20240901","doi-asserted-by":"crossref","first-page":"e1057","DOI":"10.4244\/EIJY15M10_09","article-title":"Albumin correlates with all-cause mortality in elderly patients undergoing transcatheter aortic valve implantation","volume":"12","author":"Bogdan","year":"2016","journal-title":"EuroIntervention"},{"key":"R28-12-20240901","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1016\/j.amjcard.2015.02.009","article-title":"Impact of pre-procedural serum albumin levels on outcome of patients undergoing transcatheter aortic valve replacement","volume":"115","author":"Koifman","year":"2015","journal-title":"Am J Cardiol"},{"key":"R29-12-20240901","doi-asserted-by":"crossref","first-page":"532","DOI":"10.21037\/acs.2017.09.06","article-title":"Impact of frailty markers on outcomes after transcatheter aortic valve replacement: Insights from a Japanese multicenter registry","volume":"6","author":"Shimura","year":"2017","journal-title":"Ann Cardiothorac Surg"},{"key":"R30-12-20240901","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jcin.2019.08.015","article-title":"The effect and relationship of frailty indices on survival after transcatheter aortic valve replacement","volume":"13","author":"Kiani","year":"2020","journal-title":"JACC Cardiovasc Interv"}],"container-title":["Annals of Cardiac Anaesthesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/aca.aca_114_21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T18:40:36Z","timestamp":1787769636000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/aca.aca_114_21"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.4103\/aca.aca_114_21","relation":{},"ISSN":["0971-9784"],"issn-type":[{"value":"0971-9784","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]}}}